Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 22 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of TTK Healthcare Ltd

About the Company - TTK Healthcare Ltd

TTK Healthcare Ltd. is a Public Limited Listed company incorporated on 21/05/1958 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1958PLC003647 and registration number is 003647. Currently Company is involved in the business activities of Manufacture of other rubber products. Company’s Total Operating Revenue is Rs. 599.24 Cr. and Equity Capital is Rs. 14.13 Cr. for the Year ended 31/03/2022.
PharmaceuticalsNo 6, Cathedral Road, Chennai (Madras) Tamil Nadu
NamePosition Held
Mr. T T RaghunathanExecutive Chairman
Mr. S KalyanaramanWhole Time Director
Mr. R K TulshanDirector
Mr. K ShankaranDirector
Dr.(Mrs.) Vandana R WalvekarDirector
Mr. Girish RaoDirector
Mr. S BalasubramanianDirector
Mr. N Ramesh RajanDirector
Mr. V RanganathanDirector
Dr. T T MukundDirector

TTK Healthcare Ltd. Share Price Update

Share PriceValue
Previous Day₹1,482.15

Basic Stock Data of TTK Healthcare Ltd

Market Cap 2,106 Cr.
Current Price 1,490
High / Low1,584/828
Stock P/E32.4
Book Value 688
Dividend Yield0.67 %
ROCE10.1 %
ROE99.7 %
Face Value 10.0

Data Source:

Competitors of TTK Healthcare Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
J B Chemicals & Pharmaceuticals Ltd 25,702 Cr. 1,6571,940/87550.0 1750.52 %22.4 %17.6 % 1.00
Torrent Pharmaceuticals Ltd 88,045 Cr. 2,6012,700/1,44661.5 1980.85 %19.8 %20.0 % 5.00
Panacea Biotec Ltd 977 Cr. 160202/107 1380.00 %10.3 %10.9 % 1.00
Sun Pharmaceuticals Industries Ltd 3,69,282 Cr. 1,5391,555/92239.5 2330.75 %16.4 %16.6 % 1.00
Alembic Ltd 2,633 Cr. 103107/55.210.3 82.52.16 %4.18 %8.67 % 2.00
Industry Average219 Cr53.432.26165.30.86%14.62%14.75%2

TTK Healthcare Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Operating Profit121063854481510105
OPM %7%7%5%2%5%3%2%2%5%8%5%5%3%
Other Income375151012606131212151616
Profit before tax11128141412604131623212218
Tax %28%17%22%7%15%13%1%23%26%27%24%26%27%
Net Profit8106131211601101217161613
EPS in Rs5.447.324.259.078.617.52425.237.018.4911.9911.0911.339.12

TTK Healthcare Ltd Quarterly Chart

TTK Healthcare Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit24202030403843502819223140
OPM %7%5%5%6%8%7%7%8%4%4%4%4%5%
Other Income576766889284264359
Profit before tax242220263629303919324865783
Tax %34%34%37%39%36%36%40%38%37%-44%13%3%
Net Profit161412162319182412464264062
EPS in Rs20.1318.2815.9520.8129.1924.1312.8617.258.7232.8729.43452.7243.53
Dividend Payout %20%22%25%22%17%21%39%29%34%18%34%2%

TTK Healthcare Ltd Profit & Loss Yearly Chart

YoY Net Profit Growth
YoY Net Profit Growth (%)-12.50%-14.29%33.33%43.75%-17.39%-5.26%33.33%-50.00%283.33%-8.70%1423.81%
Change in YoY Net Profit Growth (%)0.00%-1.79%47.62%10.42%-61.14%12.13%38.60%-83.33%333.33%-292.03%1432.51%

TTK Healthcare Ltd Growth

Compounded Sales Growth
10 Years:7%
5 Years:5%
3 Years:4%
Compounded Profit Growth
10 Years:47%
5 Years:104%
3 Years:273%
Stock Price CAGR
10 Years:12%
5 Years:18%
3 Years:37%
1 Year:58%
Return on Equity
10 Years:35%
5 Years:44%
3 Years:59%
Last Year:100%

TTK Healthcare Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital88888814141414141414
Other Liabilities8689102115128104127136152180207189185
Total Liabilities1922092402753032854074164314945591,1701,182
Fixed Assets3343545210699110988985807177
Other Assets1461651841771851772883043253954631,0831,090
Total Assets1922092402753032854074164314945591,1701,182

TTK Healthcare Ltd Reserves and Borrowings Chart

TTK Healthcare Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 624133937182517209645-26
Cash from Investing Activity -4-1-15-49-275-2210-13-77-3033
Cash from Financing Activity -1-223-11-23-7-31-10-17-10-12
Net Cash Flow1220-7-00-4-4-425-6

TTK Healthcare Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days393434343324354743463346
Inventory Days645264626665807710112310289
Days Payable7055565053100130101121170134131
Cash Conversion Cycle3231414646-11-162223-214
Working Capital Days1-8-12-14-22-9-11013-18-1517
ROCE %27%21%17%20%23%18%15%15%8%6%8%10%

TTK Healthcare Ltd Financial Efficiency Indicators Chart

TTK Healthcare Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
No. of Shareholders12,86115,97417,11516,41615,81715,22814,61714,99515,81816,10915,67216,651

TTK Healthcare Ltd Shareholding Pattern Chart

No. of TTK Healthcare Ltd Shareholders

TTK Healthcare Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Axis ELSS Tax Saver Fund1723860.0825.52

TTK Healthcare Ltd ROCE Trend

TTK Healthcare Ltd EPS Trend

TTK Healthcare Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)452.7229.4332.878.7217.25
Diluted EPS (Rs.)452.7229.4332.878.7217.25
Cash EPS (Rs.)461.7938.3442.0818.8927.63
Book Value[Excl.RevalReserv]/Share (Rs.)671.59230.16205.40173.09174.81
Book Value[Incl.RevalReserv]/Share (Rs.)674.71233.28208.52176.21177.94
Dividend / Share (Rs.)10.0010.
Revenue From Operations / Share (Rs.)513.16424.08336.91457.01444.35
PBDIT / Share (Rs.)56.3927.0120.7026.2340.56
PBIT / Share (Rs.)47.3318.1111.4916.0630.18
PBT / Share (Rs.)43.6217.5816.0113.7527.78
Net Profit / Share (Rs.)452.7229.4332.878.7217.25
PBDIT Margin (%)10.986.366.145.749.12
PBIT Margin (%)
PBT Margin (%)8.504.144.753.006.25
Net Profit Margin (%)88.226.949.751.903.88
Return on Networth / Equity (%)67.4112.7816.005.039.86
Return on Capital Employeed (%)6.977.565.318.7316.47
Return On Assets (%)54.677.449.392.855.86
Total Debt / Equity (X)
Asset Turnover Ratio (%)0.831.141.031.521.53
Current Ratio (X)
Quick Ratio (X)4.661.681.611.321.38
Inventory Turnover Ratio (X)2.231.921.381.641.87
Dividend Payout Ratio (NP) (%)2.2020.389.1257.3428.98
Dividend Payout Ratio (CP) (%)2.1615.657.1226.4618.09
Earning Retention Ratio (%)97.8079.6290.8842.6671.02
Cash Earning Retention Ratio (%)97.8484.3592.8873.5481.91
Interest Coverage Ratio (X)15.2111.7917.1011.3416.96
Interest Coverage Ratio (Post Tax) (X)9.535.9517.774.778.21
Enterprise Value (Cr.)639.44918.42488.79358.06861.55
EV / Net Operating Revenue (X)0.881.531.030.551.37
EV / EBITDA (X)8.0324.0616.719.6615.03
MarketCap / Net Operating Revenue (X)2.011.961.470.711.53
Retention Ratios (%)97.7979.6190.8742.6571.01
Price / BV (X)1.543.602.411.893.88
Price / Net Operating Revenue (X)2.011.961.470.711.53

TTK Healthcare Ltd Profitability Ratios (%)

TTK Healthcare Ltd Liquidity Ratios

TTK Healthcare Ltd Liquidity Ratios (%)

TTK Healthcare Ltd Interest Coverage Ratios (X)

TTK Healthcare Ltd Valuation Ratios

Fair Value / Intrinsic Value of TTK Healthcare Ltd

Fair Value: ₹22373.23

The stock is undervalued by 1,401.56% compared to the current price ₹1490

*Investments are subject to market risks

Strength and Weakness of TTK Healthcare Ltd

  1. The stock has a high average ROCE of 15.67%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -4.83, which is a positive sign.
  3. The company has higher reserves (295.54 cr) compared to borrowings (28.77 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (545.08 cr) and profit (81.92 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 34.18 and average Dividend Yield of 5.44%.
  2. The stock has a high average Cash Conversion Cycle of 18.08, which may not be favorable.

Should I Buy TTK Healthcare Ltd Share Now?

  • Considering various financial indicators, investors might exercise caution regarding investment in TTK Healthcare Ltd:
    1. Net Profit Margin: 88.22%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 6.97% (Industry Average ROCE: 15.86%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): 9.53
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 4.66
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✗ Stock P/E: 32.2 (Industry average Stock P/E: 25.24)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✓ Total Debt / Equity: 0.02
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis suggests exercising caution. It's advisable to conduct further research or consult with financial experts before considering any investment.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in TTK Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE